Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
Clinical trial NCT07022587 · RECRUITING
Trial details
- NCT number
- NCT07022587
- Sponsor
- Xijing Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-20
- Primary completion
- 2030-12-20
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.